Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8DTD

Crystal Structure of FosB from Bacillus cereus with Zinc and Phosphonoformate

Summary for 8DTD
Entry DOI10.2210/pdb8dtd/pdb
DescriptorMetallothiol transferase FosB, PHOSPHONOFORMIC ACID, ZINC ION, ... (4 entities in total)
Functional Keywordsfosfomycin, antibiotic resistance, thiol-transferase, antibiotic, dimer, transferase-antibiotic complex, transferase
Biological sourceBacillus cereus ATCC 10987
Total number of polymer chains2
Total formula weight33359.80
Authors
Travis, S.,Gilbert, N.C.,Thompson, M.K. (deposition date: 2022-07-25, release date: 2023-08-02, Last modification date: 2024-08-14)
Primary citationTravis, S.,Green, K.D.,Gilbert, N.C.,Tsodikov, O.V.,Garneau-Tsodikova, S.,Thompson, M.K.
Inhibition of Fosfomycin Resistance Protein FosB from Gram-Positive Pathogens by Phosphonoformate.
Biochemistry, 62:109-117, 2023
Cited by
PubMed Abstract: The Gram-positive pathogen is a leading cause of antimicrobial resistance related deaths worldwide. Like many pathogens with multidrug-resistant strains, contains enzymes that confer resistance through antibiotic modification(s). One such enzyme present in is FosB, a Mn-dependent l-cysteine or bacillithiol (BSH) transferase that inactivates the antibiotic fosfomycin. gene knockout experiments show that the minimum inhibitory concentration (MIC) of fosfomycin is significantly reduced when the FosB enzyme is not present. This suggests that inhibition of FosB could be an effective method to restore fosfomycin activity. We used high-throughput -based screening to identify small-molecule analogues of fosfomycin that inhibited thiol transferase activity. Phosphonoformate (PPF) was a top hit from our approach. Herein, we have characterized PPF as a competitive inhibitor of FosB from (FosB) and (FosB). In addition, we have determined a crystal structure of FosB with PPF bound in the active site. Our results will be useful for future structure-based development of FosB inhibitors that can be delivered in combination with fosfomycin in order to increase the efficacy of this antibiotic.
PubMed: 36525630
DOI: 10.1021/acs.biochem.2c00566
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.95 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon